Mi-2ß promotes immune evasion in melanoma by activating EZH2 methylation.

Li, Cang; Wang, Zhengyu; Yao, Licheng; Lin, Xingyu; Jian, Yongping; Li, Yujia; Zhang, Jie; Shao, Jingwei; Tran, Phuc D; Hagman, James R; Cao, Meng; Cong, Yusheng; Li, Hong-Yu; Goding, Colin R; Xu, Zhi-Xiang; Liao, Xuebin; Miao, Xiao; Cui, Rutao

Li, Cang; Wang, Zhengyu; Yao, Licheng; Lin, Xingyu; Jian, Yongping; Li, Yujia; Zhang, Jie; Shao, Jingwei; Tran, Phuc D; Hagman, James R; Cao, Meng; Cong, Yusheng; Li, Hong-Yu; Goding, Colin R; Xu, Zhi-Xiang; Liao, Xuebin; Miao, Xiao; Cui, Rutao.

Affiliation

Li C; Skin Disease Research Institute, The 2nd Hospital and School of Medicine, Zhejiang University, Hangzhou, 310058, China.
Wang Z; Research Center for Life Science and Human Health, Binjiang Institute of Zhejiang University, Hangzhou, 310053, China.
Yao L; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Science, Little Rock, AR, 72205, USA.
Lin X; State Key Laboratory of Molecular Oncology, School of Pharmaceutical Sciences, Tsinghua-Peking Center for Life Science, Tsinghua University, Beijing, 100084, China.
Jian Y; Zhuhai Yu Fan Biotechnologies Co. Ltd, Zhuhai, Guangdong, 51900, China.
Li Y; School of Life Sciences, Henan University, Kaifeng, 475000, China.
Zhang J; School of Life Sciences, Henan University, Kaifeng, 475000, China.
Shao J; National Key Laboratory for Novel Software Technology, Nanjing University, Nanjing, Jiangsu, China.
Tran PD; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, International Academy of Targeted Therapeutics and Innovation, College of Pharmacy, Chongqing University of Arts and Sciences, Chongqing, 402160, China.
Hagman JR; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Science, Little Rock, AR, 72205, USA.
Cao M; Department of Immunology and Genomic Medicine, National Jewish Health, Denver, CO, 80206, USA.
Cong Y; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Li HY; Key Laboratory of Aging and Cancer Biology of Zhejiang Province, Hangzhou Normal University School of Basic Medical Sciences, Hangzhou, 310058, China.
Goding CR; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Science, Little Rock, AR, 72205, USA. lih1@uthscsa.edu.
Xu ZX; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford, OX3 7DQ, UK. colin.goding@ludwig.ox.ac.uk.
Liao X; School of Life Sciences, Henan University, Kaifeng, 475000, China. 10140187@vip.henu.edu.cn.
Miao X; State Key Laboratory of Molecular Oncology, School of Pharmaceutical Sciences, Tsinghua-Peking Center for Life Science, Tsinghua University, Beijing, 100084, China. liaoxuebin@mail.tsinghua.edu.cn.
Cui R; Department of Dermatology, Shuguang Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China. 0000002623@shutcm.edu.cn.

Nat Commun ; 15(1): 2163, 2024 Mar 09.

Article in En | MEDLINE | ID: mdl-38461299

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA Helicases / Immune Evasion / Enhancer of Zeste Homolog 2 Protein / Melanoma Limits: Animals / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2024 Document type: Article Affiliation country: China Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google